J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 42 drugs in this drug class and its subclasses.
- 42 prescription (Rx)
Place in the ATC system
- J Antiinfectives for systemic use 1,101 drugs
- J05 Antivirals for systemic use 246 drugs
- J05A Direct acting antivirals 246 drugs
-
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05AF01 Zidovudine 4 drugs
- J05AF02 Didanosine 3 drugs
- J05AF04 Stavudine 2 drugs
- J05AF05 Lamivudine 7 drugs
- J05AF06 Abacavir 3 drugs
- J05AF07 Tenofovir disoproxil 9 drugs
- J05AF08 Adefovir dipivoxil 1 drug
- J05AF09 Emtricitabine 1 drug
- J05AF10 Entecavir 10 drugs
- J05AF11 Telbivudine 1 drug
- J05AF13 Tenofovir alafenamide 1 drug
-
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 42 drugs
- J05A Direct acting antivirals 246 drugs
- J05 Antivirals for systemic use 246 drugs
Active ingredients of the class
- Abacavir (abacavir sulfate) 3 drugs
- Adefovir dipivoxil 1 drug
- Didanosine 3 drugs
- Emtricitabine 1 drug
- Entecavir 5 drugs
- Entecavir (entecavir monohydrate) 5 drugs
- Lamivudine 7 drugs
- Stavudine 2 drugs
- Telbivudine 1 drug
- Tenofovir alafenamide (tenofovir alafenamide hemifumarate) 1 drug
- Tenofovir disoproxil fumarate 9 drugs
- Zidovudine 4 drugs
Drugs in the class and its subclasses
Other classes of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 73 drugs
- J05AD Phosphonic acid derivatives, direct acting antivirals 1 drug
- J05AE Protease inhibitors, direct acting antivirals 28 drugs
- J05AG Non-nucleoside reverse transcriptase inhibitors 14 drugs
- J05AH Neuraminidase inhibitors, direct acting antivirals 10 drugs
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 9 drugs
- J05AP Antivirals for treatment of HCV infections 16 drugs
- J05AR Antivirals for treatment of HIV infections, combinations 40 drugs
- J05AX Other antivirals 13 drugs
Other names of the drug class
- Czech: J05AF Nukleosidové a nukleotidové inhibitory reverzní transkriptázy
- English (United Kingdom): J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
- French: J05AF inhibiteurs de la transcriptase reverse nucléosidiques et nucléotidiques
- German: J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- German (Austria): J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- Italian: J05AF Nucleosidi e nucleotidi inibitori della transcrittasi inversa
- Polish: J05AF Nukleozydowe i nukleotydowe inhibitory odwrotnej transkryptazy
- Turkish: J05AF Nükleozid ve nükleotid ters transkriptaz inhibitörleri
- Portuguese (Brazil): J05AF Nucleosídeos e nucleotídeos inibidores da transcriptase reversa
- Slovak: J05AF Nukleozidové a nukleotidové inhibítory reverznej transkriptázy
- German (Switzerland): J05AF Nukleosidale und nukleotidale Inhibitoren der Reversen Transkriptase
- French (Switzerland): J05AF Inhibiteurs de la transcriptase reverse nucléosidiques et nucléotidiques
- Italian (Switzerland): J05AF Nucleosidi e nucleotidi inibitori della transcrittasi inversa
- Dutch: J05AF Nucleoside en nucleotide reverse-transcriptaseremmers
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class J05AF
Ask your doctor or pharmacist for advice.